Abhishek Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 14-12-2024
- Paid Up Capital ₹ 0.29 M
as on 14-12-2024
- Company Age 44 Year,
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 M
as on 14-12-2024
- Revenue 202.40%
(FY 2019)
- Profit -342.95%
(FY 2019)
- Ebitda 223.50%
(FY 2019)
- Net Worth -17.78%
(FY 2019)
- Total Assets 63.80%
(FY 2019)
About Abhishek Biotech
The Corporate was formerly known as Kay Dee Pharma Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.29 M.
The company currently has active open charges totaling ₹6.00 M.
Abhishek Goel and Kunal Goel serve as directors at the Company.
- CIN/LLPIN
U24100UP1980PTC005163
- Company No.
005163
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 1980
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Abhishek Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Goel  | Director | 12-Mar-2005 | Current |
| Kunal Goel | Director | 01-Nov-2011 | Current |
Financial Performance and Corporate Structure Insights of Abhishek Biotech.
Abhishek Biotech Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 202.4% increase. The company also saw a substantial fall in profitability, with a 342.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abhishek Biotech?
In 2019, Abhishek Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arshanti Enterprises Private LimitedActive 3 years 6 monthsAbhishek Goel and Kunal Goel are mutual person
- Trilok Infrabuild Private LimitedActive 8 years 6 months
Abhishek Goel and Kunal Goel are mutual person
- Meerut Agro Chemical Industries LimitedActive 28 years 11 months
Abhishek Goel and Kunal Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 15 Oct 2018 | ₹6.00 M | Open |
How Many Employees Work at Abhishek Biotech?
Unlock and access historical data on people associated with Abhishek Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abhishek Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abhishek Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
